Northern Trust’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
928,688
-47,382
| -5% | -$664K | ﹤0.01% | 1914 |
|
|
2025
Q1 | $15.3M | Sell |
976,070
-14,986
| -2% | -$234K | ﹤0.01% | 1792 |
|
|
2024
Q4 | $13.8M | Buy |
991,056
+54,541
| +6% | +$760K | ﹤0.01% | 1938 |
|
|
2024
Q3 | $8.71M | Buy |
936,515
+184,665
| +25% | +$1.72M | ﹤0.01% | 2148 |
|
|
2024
Q2 | $6.99M | Buy |
751,850
+2,905
| +0.4% | +$27K | ﹤0.01% | 2206 |
|
|
2024
Q1 | $7.42M | Buy |
748,945
+18,201
| +2% | +$180K | ﹤0.01% | 2235 |
|
|
2023
Q4 | $2.36M | Buy |
730,744
+247,245
| +51% | +$799K | ﹤0.01% | 2902 |
|
|
2023
Q3 | $2.57M | Buy |
483,499
+17,846
| +4% | +$94.8K | ﹤0.01% | 2802 |
|
|
2023
Q2 | $4.44M | Buy |
465,653
+78,792
| +20% | +$751K | ﹤0.01% | 2570 |
|
|
2023
Q1 | $4.26M | Buy |
386,861
+2,009
| +0.5% | +$22.1K | ﹤0.01% | 2562 |
|
|
2022
Q4 | $5.7M | Buy |
384,852
+11,151
| +3% | +$165K | ﹤0.01% | 2404 |
|
|
2022
Q3 | $7.14M | Buy |
373,701
+58,643
| +19% | +$1.12M | ﹤0.01% | 2228 |
|
|
2022
Q2 | $6.71M | Buy |
315,058
+56,121
| +22% | +$1.2M | ﹤0.01% | 2312 |
|
|
2022
Q1 | $4.99M | Sell |
258,937
-11,016
| -4% | -$212K | ﹤0.01% | 2589 |
|
|
2021
Q4 | $5.6M | Sell |
269,953
-566
| -0.2% | -$11.7K | ﹤0.01% | 2619 |
|
|
2021
Q3 | $6.46M | Sell |
270,519
-19,584
| -7% | -$468K | ﹤0.01% | 2576 |
|
|
2021
Q2 | $7.92M | Buy |
290,103
+23,285
| +9% | +$635K | ﹤0.01% | 2532 |
|
|
2021
Q1 | $7.72M | Buy |
266,818
+26,563
| +11% | +$768K | ﹤0.01% | 2468 |
|
|
2020
Q4 | $6.76M | Buy |
240,255
+29,987
| +14% | +$843K | ﹤0.01% | 2495 |
|
|
2020
Q3 | $6.16M | Buy |
210,268
+81,938
| +64% | +$2.4M | ﹤0.01% | 2404 |
|
|
2020
Q2 | $3.88M | Buy |
128,330
+19,871
| +18% | +$601K | ﹤0.01% | 2667 |
|
|
2020
Q1 | $3.23M | Buy |
+108,459
| New | +$3.23M | ﹤0.01% | 2566 |
|